ID
Bron
Aandoening
Breast cancer
Shared decision making
Implementation
Decision aid
Patient communication
Borstkanker
Gezamelijk beslissen
Keuzehulpen
Implementatie
Patient communicatie
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
With respect to our hypotheses on frequency of registering indication for a patient decision aid in the Multidisciplinary Board, for handing out and actually logging in, and assuming that that we can include 150 patients in total (5 hospitals, 30 patients per hospital), we expect that:<br>
- in 120 patients the indication for the decision aid is registered in the Multidisciplinary tumor board, i.e. in 80%, with a 95% CI of 74-86%. <br>
- in 105 patients the personalized decision aid will be handed out, i.e. in 70% with a 95% CI of 63-77%.<br>
- 90 patients will actually log in to the patient decision aid, i.e. 60% with a 95% CI of 53-67%.
Achtergrond van het onderzoek
Rationale: Practice variations in treatment of early-stage breast cancer should be determined by the preferences of well-informed patients. There is, however, substantial practice variation in type of surgery in breast cancer between Dutch hospitals. Involving patients in the decision making process is seen as an important strategy to reduce unwarranted variation in preference-sensitive care. In an earlier study, we developed a personalized patient decision aid, which was pilot tested in 4 hospitals. Based upon this pilot test, we adapted the implementation strategy. Currently, the decision aid is being implemented in the hospitals in the OncoZON region, and in the hospitals that had participated in the pilot study.
Objectives: The main aim of the current study is to further investigate implementation challenges, by investigating the actual implementation rate at several levels, by investigating barrieres and facilitators for implementation, and by investigating patient-experiences on shared decision making.
Study design: This study concerns an observational study, a prospective process evaluation of the implementation of the decision aid.
Study population: Patients with newly diagnosed breast cancer, stage I or II who are eligible for breast conserving therapy or mastectomy can be included. We expect that 5 hospitals will each include 30 patients in a period of 6 months. In addition, in each hospital, all breast surgeons, medical oncologists, radiation oncologists, reconstructive surgeons, nurse practitioners and nurses taking part in the education and decision-making process are invited to participate in implementation of SDM.
Onderzoeksopzet
Audits and interviews: immediately after implementation
Patient questionnaires: during implementation.
Onderzoeksproduct en/of interventie
The intervention consists of offering patients a personalized patient decision aid.
Publiek
W. Savelberg
Maastricht 6200 MD
The Netherlands
043-3882336
wilma.savelberg@maastrichtuniversity.nl
Wetenschappelijk
W. Savelberg
Maastricht 6200 MD
The Netherlands
043-3882336
wilma.savelberg@maastrichtuniversity.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients with newly diagnosed breast cancer, stage I or II who are eligible for breast conserving therapy or mastectomy
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Not understanding the Dutch language
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5614 |
NTR-old | NTR5721 |
Ander register | KWf Ad6 shared decision making : 2014-7024 |